ArticleInternational journal of clinical and experimental medicine2015

Efficacy of FOLFOXIRI versus XELOXIRI plus bevacizumab in the treatment of metastatic colorectal cancer.

Yuzhuo Cheng et al.PubMed ↗Full text ↗

No numbers read from the abstract.